e-learning
resources
Munich 2006
Tuesday 05.09.2006
Treatment and complications of treatment of lung cancer and malignant pleural effusions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
F. Vlastos, N. Cassou, C. Clement-Duchene, C. Carnin, N. Martinet, Y. Martinet (Athens, Greece; Vandoeuvre les Nancy, Nancy, France)
Source:
Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session:
Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session type:
Electronic Poster Session
Number:
4326
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Vlastos, N. Cassou, C. Clement-Duchene, C. Carnin, N. Martinet, Y. Martinet (Athens, Greece; Vandoeuvre les Nancy, Nancy, France). Are biphosphonates efficient in the adjuvant treatment of lung cancer?. Eur Respir J 2006; 28: Suppl. 50, 4326
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Adjuvant therapy in NSCLC
Source: Annual Congress 2007 - Clinical year in review
Year: 2007
Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013
Cryotherapy as an adjuvant to radiotherapy in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005
Effectiveness of chemotherapy for advanced lung cancer in the elderly
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003
Neoadjuvant and adjuvant treatment for operable nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 244–259
Year: 2009
Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015
Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014
Mianserin therapy in advanced lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002
Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011
Optimal integration of chemo- and radiotherapy in small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006
Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001
Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007
Adjuvant and neoadjuvant therapy in nonsmall cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Clinical year in review
Year: 2006
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept